InvestorsHub Logo
Followers 1
Posts 160
Boards Moderated 0
Alias Born 10/17/2013

Re: Biobillionair post# 22068

Friday, 11/22/2013 1:57:37 PM

Friday, November 22, 2013 1:57:37 PM

Post# of 427212
BB,

IMO, there was no fatal mistake made. The company is exhausting all available options due to the FDA mishandling of the SPA agreement and Adcom. Because the meeting was denied due to procedural missteps does not imply incompetence. In the end however, you may be correct that JZ needs to go for Amarin to have any chance going fwd.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News